Clinical Trials Directory

Trials / Completed

CompletedNCT01895699

The Effect of Contrast Agent on Endothelial Function in Healthy Men

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Xiang Guang-da · Academic / Other
Sex
Male
Age
20 Years – 30 Years
Healthy volunteers
Accepted

Summary

Contrast medium is essential for diagnosis of many diseases. However, recent studies showed that contrast agents can induce renal injury and is associated with poor long-term clinical outcome, especially in diabetes. To date, no data are available on the relationship between contrast medium and endothelial function. Endothelial dysfunction is known to precede atherosclerosis and is considered a risk marker for future development of cardiovascular disease. Therefore, we hypothesized that contrast agents may induce endothelial dysfunction in healthy men. In addition, we hypothesized that contrast induced endothelial dysfunction via free radicals. Thus, we also test alpha-lipoic acid whether or not protect endothelial dysfunction induced by contrast agents.

Conditions

Interventions

TypeNameDescription
OTHERContrast agent

Timeline

Start date
2013-07-01
Primary completion
2015-07-01
Completion
2015-07-01
First posted
2013-07-10
Last updated
2015-08-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01895699. Inclusion in this directory is not an endorsement.

The Effect of Contrast Agent on Endothelial Function in Healthy Men (NCT01895699) · Clinical Trials Directory